This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Struggling to stand out in medical sales? This episode is your blueprint for crafting a resume that gets noticed, even if you don’t have direct sales experience. Learn how to position your background as an asset, highlight your sales potential, and structure your resume for maximum impact. We’ll also dive into LinkedIn strategies to boost your visibility and connect with decision-makers, plus real success stories from professionals who made the leap.
By reimagining clinical trials as the initial step in designing a service ecosystem, organizations can accelerate time to delivery and lay the groundwork for successful commercialization. The post Building Service Infrastructure for “Made-To-Order” Therapies appeared first on MedCity News.
A version of this article was previously published on PharmaPhorum. As the demands of modern healthcare grow, new therapies are introduced at record speeds, and guidelines are quickly updated, it is key that medical education evolves to keep up. Traditional medical educationreliant on didactic presentations with limited opportunity for interactionis plagued by a range of issues, including suboptimal participation and no or poor personalisation ability.
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Sales teams today need training that feels real, moves fast, and delivers measurable results. Thats why were introducing major enhancements to Quantified’s AI role play technology giving sales reps a more lifelike, adaptive, and effective way to practice their conversations. The latest updates focus on three critical areas: Faster deployment Get AI avatars up and running in less time, reducing training delays More realistic interactions Improved responsiveness and expressiveness make AI
J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder. The disappointing result follows the Phase 3 failure of a Neumora Therapeutics drug that addresses the same central nervous system target. The post Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy appeared first on MedCity News.
J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depressive disorder. The disappointing result follows the Phase 3 failure of a Neumora Therapeutics drug that addresses the same central nervous system target. The post Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy appeared first on MedCity News.
Voyager Therapeutics’ progress with drug candidates targeting tau marks a step in how the industry is walking multiple paths toward new therapeutic options.
A team of researchers in Japan have developed a novel artificial photosynthesis method that transforms waste organic compounds into valuable pharmaceuticals and energy using sunlight and water. The approach, known as artificial photosynthesis directed toward organic synthesis (APOS), represents a major step forward in sustainable chemical manufacturing.
Pharma-exclusive Webinar: From Clicks to Outcomes: Measuring the Impact of Your Medical Education Platform About the webinar Tired of building medical education programs that fail to deliver? Impetus Digital invites you to our free webinar on May 13 and 14 , designed specifically for life science professionals who are ready to build a medical education platform that truly engages HCPs and drives measurable results.
AbbVie is licensing rights to a drug from Gubra that has encouraging early clinical data in obesity. The once-weekly injectable peptide is a dual agonist of the amylin and calcitonin receptors, both of which play key roles in metabolism. The post AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic appeared first on MedCity News.
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
A paper published by the Drug Safety Research Unit (DSRU) in the British Journal for Clinical Pharmacology , has asserted the need for ongoing assessment of the safety and effectiveness of the Alzheimers drug lecanemab in the real-world clinical setting. The Medicines and Healthcare products Regulatory Agency (MHRA) approved the drug for use in the UK in August 2024.
On February 21, 2025 , the FDA officially determined that the shortage of semaglutide injection products has been resolved. Semaglutide is a glucagon-like peptide 1 (GLP-1) medication whose shortage has been in effect since 2022. Originally developed to treat type 2 diabetes, semaglutide and other similar GLP-1 medications have found demand in the market as weight loss medications when used together with diet and exercise to help individuals with at least one weight-related medical condition.
Wegovy will ship directly to eligible patients through NovoCare, an online pharmacy established by Novo Nordisk. The products price matches a recent price cut for Zepbound offered by Eli Lilly through its own direct-to-patient online platform. The post Novo Nordisk Launches Lower-Cost Wegovy, Following Eli Lilly Into Direct-to-Patient Sales appeared first on MedCity News.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
The company's vice president and general manager of U.S. business operations explains how Amgen is going to deliver on its “ambitious growth aspirations.
Introduction In the highly regulated world of pharmaceutical marketing , mastering Google Ads management can be a game-changer. With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. However, the landscape isnt simple.
Those that fail to adapt their workforce strategies will remain stuck in crisis mode, scrambling to fill shifts and struggling to retain nurses in the face of a nursing shortage. But for those willing to welcome change, the opportunity is immense. The post Healthcares Workforce Blueprint is Out Of Date. Its Time For A Change appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with drugs from Novo Nordisk, Eli Lilly and Zealand.
Introduction Pharmaceutical marketing has evolved. Traditional advertising methods alone no longer cut it in todays digital-first world. Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. But heres the challenge: strict industry regulations make social media advertising tricky for pharma marketers.
Q. Creating revenue growth and shareholder value are table stakes for aspiring CEOs. With over five-thousand participants in last year’s executive education programming offered at MIT Sloan [1], several of these leaders have ambitions to secure executive roles. As a CEO who successfully engineered two billion-dollar pharma transactions [2] with AstraZenca and Novo Nordisk during COVID-19 when many organizations struggled to keep the lights on [3], what are the top skills which aspiring CEO
[Sponsored] MedCity News Editor in Chief Arundhati Parmar moderated a webinar with Elation Health executives Dr Sara Pastoor, head of primary care advancement, and Meaghan Sullivan, senior sales engineer. The post How Can EHRs Support the Shift to Value-Based Care and Reduce Clinician Burnout? appeared first on MedCity News.
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Introduction Pharmaceutical marketing has changed. Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. Thats where PPC advertising strategies come into play. But heres the challenge pharma PPC isnt like other industries. Regulatory restrictions, compliance concerns, and complex audience targeting make it one of the toughest sectors to master in digital advertising.
In the fast-paced and ever-evolving world of finance, it takes more than just industry knowledge to succeed. The ability to navigate uncertainty, maintain a growth mindset, and inspire a team to perform at their highest level is crucial to long-term success. Financial organizations must remain agile, resilient, and forward-thinking to stay ahead of the competition.
[Sponsored] In a webinar sponsored byJotform, scheduled for Thursday, March 13 at 1 pm ET, panelists will discuss how health tech companies approach data automation and how practices implement it. The post Making Automation a Mainstream Function in Healthcare Practices appeared first on MedCity News.
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
The M&A resurgence has been predicted for years, but the industry is still holding out, partly because the ideal range for biotech valuations has been harder to find.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
130 
Let's personalize your content